Bacskai BJ, Frosch MP, Freeman SH, Raymond SB, Augustinack JC, Johnson KA, Irizarry MC, Klunk WE, Mathis CA, Dekosky ST, Greenberg SM, Hyman BT, Growdon JH. Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report. Arch Neurol. 2007 Mar;64(3):431-4. PubMed.

Recommends

Please login to recommend the paper.

Comments

  1. This case report demonstrates a correlation between PIB retention in the living human brain and amyloid pathology at autopsy. It provides further support for the possibility of using this imaging technique to detect and track fibrillar amyloid pathology in the living human brain. Future studies will determine the extent to which PIB and other imaging techniques could be used in the diagnosis, preclinical detection, and tracking of Alzheimer disease and the evaluation of promising amyloid-modifying therapies.

    View all comments by Eric M. Reiman

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. It Is Official: Autopsy Verifies Human PIB-Amyloid Connection
  2. Salzburg: Amyloid Imaging Update
  3. Toronto: Last Gift to Science—Hospice Patients Validate Amyloid Ligand
  4. eFAD Research Surprise: In Mutation Carriers, Amyloid Starts in Striatum
  5. Brain of First PIB-Imaged Patient Yields Clues to Alzheimer’s Disease
  6. Merck Symposium: Surmounting the Blood-brain Barrier in Dementia Research
  7. Dyeing Worms for an Extra-Long, Healthy Lifespan?